New hope for blood cancer patients after stem cell transplantation
Researchers in Leipzig have developed a new method to prevent dangerous rejection reactions after blood stem cell transplants. The Fraunhofer Institute for Cell Therapy and Immunology treats donor cells with special antibodies prior to transplantation. Unlike previous approaches, this therapy does not weaken the entire immune system. Initial tests in the laboratory have been very promising.